BioSpace News Archive

Vivera Pharmaceuticals, Inc. a California -based pharmaceutical company focused on putting patients first, has announced the filing of two new patents with the United States Patent and Trademark Office. These patents are related to the Company’s current line of antibodies testing offerings. When approved, Vivera’s patents will

On June 4 th , Immunovia announced a Directed Share Issue raising ~400 MSEK in capital, resulting in one of the largest fundraising for a non-US based diagnostics company. Proceeds from this Directed Share Issue will be used for the commercialization activities associated with the launch of IMMray ™ PanCan-d. These activities include

Dr. Elizabeth O’Day will lead personalized medicine investment and adoption efforts globally during three-year term.

ICAN, a regional leader in pediatric rehabilitative therapy, is launching a new Statewide Telehealth initiative, ICANational. ICAN’s history of a comprehensive and innovative clinic experience providing speech, occupational and physical therapy will now be accessible to every child in Washington State , due to this pioneering telehea

Vasoptic Medical Inc., a Maryland -based medical device company, announced today that the company received 510(k) clearance from the U.S. Food & Drug Administration to market its XyCAM RI™—a non-invasive retinal imager designed to capture and provide dynamic blood flow information for clinical use. The XyCAM RI can allow ophthalmologis

Treatment with LEAF-1401 exposes the tumor to 20-times more pentaglutamated pemetrexed than conventional pemetrexed. Polyglutamated pemetrexed has been shown to be 80-times more potent than pemetrexed in inhibiting thymidylate synthase (TS), a key enzyme in the folate pathway . Pemetrexed (Alimta ® ) is today one of the leading backbone chemotherapies for lung cancer in the wo

Applied Molecular Transport (Nasdaq: AMTI), a clinical-stage biopharmaceutical company, today announced the closing of its initial public offering of 12,650,000 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase up to 1,650,000 additional shares, at a public offering price of $14.00 per share.

Vanguard Scientific Systems, Inc., a premier provider of equipment, systems, and performance solutions servicing the botanical extraction industry, is hosting the second of a four-part webinar series featuring leading industry experts talking about the business of hemp and cannabis extraction.

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the appointment of Lori Kunkel, M.D., to its board of directors

BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has established an expanded access program (EAP) with oral, once-daily berotralstat, an investigational drug, for patients with hereditary angioedema (HAE) in the United States.